BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9422110)

  • 41. Use of the gel-based DiaMed-ID microtyping system for crossmatching enhances sensitivity.
    Kaur R; Kakkar N; Dhanoa J
    Indian J Pathol Microbiol; 2003 Oct; 46(4):617-20. PubMed ID: 15025357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can blood group O red cells of donor origin acquire weak group A reactivity through serum A transferase of the recipient after bone marrow transplantation?
    Wichmann MG; Haferlach T; Suttorp M; Zhang Y; Neppert J
    Beitr Infusionsther Transfusionsmed; 1994; 32():146-8. PubMed ID: 9422108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation.
    Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Fujimori K; Sato T; Satomi S
    Ther Apher Dial; 2007 Oct; 11(5):319-24. PubMed ID: 17845390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ABO-incompatible organ and bone marrow transplantation: current status.
    Wu A; Bühler LH; Cooper DK
    Transpl Int; 2003 May; 16(5):291-9. PubMed ID: 12719804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A simple and reliable method to blood type monkeys using serum samples.
    Chen S; Wei Q; Li J; Xiang Y; Guo H; Ichim TE; Chen S; Chen G
    Transpl Int; 2009 Oct; 22(10):999-1004. PubMed ID: 19298252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation.
    Zupańska B; Zaucha JM; Michalewska B; Malinowska A; Brojer E; Hellmann A
    Transfusion; 2005 Jan; 45(1):16-20. PubMed ID: 15647013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The transfusion aspects of allogeneic bone marrow transplantation].
    Fregatova LM; Volkova OIa; Shavva SA; Platonova GG; Afanas'ev BV
    Ter Arkh; 1998; 70(7):67-9. PubMed ID: 9742642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erythrocyte-magnetized technology: an original and innovative method for blood group serology.
    Bouix O; Ferrera V; Delamaire M; Redersdorff JC; Roubinet F
    Transfusion; 2008 Sep; 48(9):1878-85. PubMed ID: 18522706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone marrow harvesting for malignant disease.
    Maitland JA; Treleaven JG; Clink HM
    Eur J Surg Oncol; 1986 Mar; 12(1):5-8. PubMed ID: 3514274
    [No Abstract]   [Full Text] [Related]  

  • 50. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new concept of accommodation in ABO-incompatible kidney transplantation.
    Takahashi K
    Clin Transplant; 2005; 19 Suppl 14():76-85. PubMed ID: 15955174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Matching for ABO blood groups and HLA tissue types in transplantation with special reference to bone marrow transplantation].
    Jakobsen BK; Dickmeiss E; Jacobsen N; Svejgaard A
    Ugeskr Laeger; 2003 Dec; 165(50):4837-9. PubMed ID: 14716899
    [No Abstract]   [Full Text] [Related]  

  • 53. Analysis of ABO chimera from peripheral red cells and reticulocytes by flow cytometry and micro gel column technique in patients post-ABO-incompatible HSCT.
    Chen J; Liu F
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29226393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elimination of antibodies by plasma exchange in ABO incompatible bone marrow transplantation.
    Gasparović V; Labar B; Puljević D; Skodlar J; Bogdanić V; Ivanović D; Gjurasin M
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():109. PubMed ID: 2627596
    [No Abstract]   [Full Text] [Related]  

  • 55. [External national quality control of blood group typing 1983-92. Significance for quality assurance in transfusion medicine].
    Heier HE; Kornstad L
    Tidsskr Nor Laegeforen; 1993 Oct; 113(25):3155-8. PubMed ID: 8273042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Improvement of absorption-elution test using commercially available anti-A, anti-B monoclonal antibodies--ABO blood typing from hair samples].
    Ohmori T; Sato H
    Nihon Hoigaku Zasshi; 1999 Nov; 53(3):338-44. PubMed ID: 10723968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey.
    Tanabe K
    Transplantation; 2007 Dec; 84(12 Suppl):S13-6. PubMed ID: 18162979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
    Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
    Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prenatal AB0(H) blood group determination of amniotic fluid cells by mixed cell agglutination].
    Keil W; Takatsu A; Geserick G; Ishiyama I; Kaiser B
    Zentralbl Gynakol; 1982; 104(20):1316-24. PubMed ID: 7158152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.